类风湿性关节炎治疗药Fostamatinib disodium
被引量：1
摘要
脾酪氨酸激酶（spleen tyrosine kinase,SYK）为一种非受体型酪氨酸蛋白激酶,具有广泛的生物活性,其在免疫细胞的成熟和激活中发挥着重要作用,
出处
《药学进展》
CAS
2011年第8期380-382,共3页
Progress in Pharmaceutical Sciences
同被引文献41
-
1陈桂敏,代林刚,贺金.类风湿性关节炎相关机制研究进展[J].海南医学院学报,2007,13(3):292-294. 被引量：10
-
2TANIGUCHI T,KOBAYASHI T,KONDO J,et aI. Molecular cloning of a porcine gene Syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis [J]. J Biol Chern, 1991 , 266 (24) : 15790 - 15796.
-
3RICCABONI M, BIANCHI I, PETRILLO P. Spleen tyrosine kinases , biology, therapeutic targets and drugs [J]. Drug Discov Today, 2010, 15 ( 13/14) : 517-530.
-
4KELLY V, GENOVESE M. Novel small molecule therapeutics in rheumatoid arthritis [J]. Rheumatology,2013,52(7) :1155 -1162.
-
5ARIAS-PALOMO E, RECUERO-CHECA M A, BUSTELO X R, et aI. Conformational rearrangements upon Syk auto-phosphorylation [J]. BBA-Proteins Proteom,2009,1794(8) :1211 -1217.
-
6YANAGIS,INATOMER,TAKANOT,etai. Syk expression and novel function in a wide variety of tissues [J]. Biochem Biopharm Res Communj Ztlll'l , 288(3) :495 -498.
-
7KLEINAU S, MARTINS SON P, HEYMAN B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcgamma receptors [J]. J Exp Med,2000,191(9) :1611-1666.
-
8LI B-K, CONG Y, YANG X G, et al. In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method [J]. Comput BioI Med, 2013 ,43 (4) :395 -404.
-
9MELTZER E O,BERKOWITZ R B,GROSSBARD E B. An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment [J]. J Allergy Clin Immun, 2005 , 115(4) :791 -796.
-
10PINE P R, CHANG B, SCHOETTLER N, et aI. Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor [J]. Clin Immunol, 2007 , 124 (3) :244 -257.
-
1Fostamatinib用于治疗慢性特发性血小板减少性紫癜的Ⅲ期临床试验达首要终末指标[J].中国执业药师,2016,13(11):23-23.
-
2Bukong TN,邵爽,王中峰.脾酪氨酸激酶抑制剂在大量酗酒所诱发的酒精性肝损伤、脂肪变性以及炎症反应中的治疗效果[J].临床肝胆病杂志,2016,32(7):1353-1353.
-
3刘夙璇(综述),谌卫(综述),于光(审校),李保春(审校).狼疮性肾炎中树突状细胞与Th1／Th2的相互作用[J].国际泌尿系统杂志,2008,28(3):398-402. 被引量：1
-
4朱晓红.类风湿性关节炎治疗药—Infliximab[J].国外新药介绍,2001(2):6-7.
-
5李晓东.类风湿性关节炎治疗药的研发进展及趋势[J].国外医药（合成药．生化药．制剂分册）,2002,23(6):334-335.
-
6武晓静,邵宗鸿,阮二宝,付蓉,王国锦,刘鸿,吴玉红,宋嘉,邢莉民,瞿文,关晶,李丽娟,王晓明,刘惠,王一浩,王化泉.CD22信号异常在免疫相关性全血细胞减少症发病机制中的作用[J].中华医学杂志,2015,95(26):2066-2069. 被引量：5
-
7fostamatinib在IIb期研究中显示对类风湿性关节炎有积极疗效[J].国外药讯,2010(11):23-23.
-
8李晓明（摘）.2008年12月份美国FDA批准的NDA[J].国外药讯,2009(1):7-8.
-
9郑永华,陆晶晶,郭忠良,任涛,梁永杰.RNA干扰靶向抑制酪氨酸蛋白激酶对哮喘小鼠树突状细胞功能的影响[J].中国呼吸与危重监护杂志,2009,8(5):487-491. 被引量：2
-
10李龙,余勤,岳红梅.表皮生长因子受体与肺纤维化及肺癌的关系[J].国际呼吸杂志,2006,26(8):629-631. 被引量：2
